ardiovascular mortality in RA patients, traditional risk factors for cardiovascular disease, including dyslipidemia, are not necessarily predictive of events for patients with RA.49 Despite the lipid abnormalities seen with TCZ, clinical cardiovascular events have not been increased with TCZ therapy in the trials and no studies have been published assessing LDL particle size.